. 2021 Jun 9;9:e11528. doi: 10.7717/peerj.11528

Table 2. Relationship between miRNA-30a levels and clinicopathological features among patients with lung cancer.

Clinicopathological features	Subgroup	Subjects	miRNA-30a relative expression
			Mean ± SD	p-value
Tissue type	SCLC	15	0.72 ± 0.58
	NSCLC	84	0.74 ± 0.55	0.911
Tissue type subgroup	SCC	22	0.71 ± 0.44
	ADC	60	0.76 ± 0.59
	SCLC	15	0.72 ± 0.58	0.924
Age, years	≤60	51	0.69 ± 0.55
	>60	48	0.79 ± 0.55	0.387
Sex	Male	62	0.75 ± 0.58
	Female	37	0.71 ± 0.50	0.710
Smoking	Yes	56	0.77 ± 0.59
	No	43	0.69 ± 0.49	0.473
Clinical TNM stage	I–IIA	22	0.98 ± 0.64
	IIB–IV	62	0.66 ± 0.54	0.025^*

Notes.

p < 0.05.